Chemometec A/S
CSE:CHEMM

Watchlist Manager
Chemometec A/S Logo
Chemometec A/S
CSE:CHEMM
Watchlist
Price: 487.6 DKK -0.69%
Market Cap: 8.5B DKK
Have any thoughts about
Chemometec A/S?
Write Note

Chemometec A/S
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chemometec A/S
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Chemometec A/S
CSE:CHEMM
Cash from Investing Activities
-kr43.5m
CAGR 3-Years
-21%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
G
Gubra A/S
CSE:GUBRA
Cash from Investing Activities
-kr351.4m
CAGR 3-Years
-265%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Chemometec A/S
Glance View

Market Cap
8.5B DKK
Industry
Life Sciences Tools & Services

Chemometec A/S, a Danish firm founded in the late 1990s, has carved a niche in the specialized world of biotech instrumentation. The company is renowned for developing and manufacturing high-precision cell counting and analysis instruments used predominantly in the life sciences sector. Its flagship product, the NucleoCounter®, has gained significant traction in laboratories and production facilities worldwide. This product stands out due to its accuracy and ease of use in counting various types of cells, whether in research or pharmaceutical production settings. Unlike traditional methods, Chemometec’s technology enables researchers to save time and reduce error, which is invaluable for laboratories looking to enhance their workflow efficiencies. Revenue for Chemometec is primarily generated through the sale of its advanced instruments and associated consumables, along with providing expert services that support the integration and maintenance of these technologies. The company's business model capitalizes on the growing global demand for sophisticated biomedical research tools, as innovation in the drug development and biotechnology sectors accelerates. By continuously investing in R&D, Chemometec not only ensures its products remain cutting-edge but also expands its applicability across new areas in the life sciences field. The strategy of maintaining close relationships with its end-users ensures that as the scientific landscape evolves, Chemometec is well-positioned to adapt and grow.

CHEMM Intrinsic Value
324.51 DKK
Overvaluation 33%
Intrinsic Value
Price

See Also

What is Chemometec A/S's Cash from Investing Activities?
Cash from Investing Activities
-43.5m DKK

Based on the financial report for Jun 30, 2024, Chemometec A/S's Cash from Investing Activities amounts to -43.5m DKK.

What is Chemometec A/S's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-10%

Over the last year, the Cash from Investing Activities growth was -7%. The average annual Cash from Investing Activities growth rates for Chemometec A/S have been -21% over the past three years , -10% over the past five years .

Back to Top